has risen since the beginning of this year, there is loss on exchange rate for this period. Expenses Selling and service Expenses Baht Million 2018 2019 +/(-) +/(-) % Expense from Event 10.03 2.68 (7.35
flows from (used in) financing activities (38,053) 62,502 (62,774) 151,922 Net decrease in cash and cash equivalents (16,584) (26,000) (14,849) (31,224) Cash and cash equivalents at beginning of the
million baht due to being in the beginning and expanding period. Expenses of GWM increased from the same period of last year by 3.37 million baht and expenses of NCL Singapore subsidiary increased by 1.92
beginning of period 50.34 96.78 -46.44 -47.99% Net cash flows from operating activities 152.69 -21.20 173.89 -820.08% Net cash flows used in investing activities -333.77 -18.60 -315.16 -1694.16% Net cash
approximately 4-6 months for customers’ awareness and regular use of service which causes income to reach the Company’s standard. Therefore, depreciation cost rises over an income at the beginning period of kiosk
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
% change Cash and cash equivalents at beginning of period 50.34 96.78 -46.44 -48% Net cash flows from operating activities 27.24 38.48 -11.24 -29% Net cash flows used in investing activities -350.57 -33.35
CASH FLOW SNAPSHOT 195 384 (338) 834 1,073 Beginning cash (31-Dec-17) CFO CFI CFF Ending cash (30-Sep-18) 8 MD&A 3Q 2018 (ended 30 September 2018) MASTER AD PLC MANAGEMENT DISCUSSION & ANALYSIS 3Q 2018 6
issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures